Inbunden, Engelska, 2026

Genetic Editing for Healthcare

Advances in Disease Management

Av Bhupinder Singh, Rishabha Malviya, Sahil Lal, Sathvik Belagodu Sridhar

2248 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

This book presents a focused and timely exploration of genome editing and its transformative impact on modern medicine. Integrating interdisciplinary perspectives, the volume examines how emerging genetic technologies are reshaping the prevention, diagnosis, and treatment of complex diseases.The book outlines the molecular foundations of key genome-editing tools, including CRISPRCas9, TALENs, and zinc-finger nucleases, explaining their mechanisms and expanding role in biomedical research. It then moves to practical applications, highlighting case studies in areas such as cancer treatment and precision medicine, demonstrating how gene-editing technologies are improving patient outcomes.Beyond technical advances, the volume addresses critical ethical, legal, and regulatory considerations, including biosafety, intellectual property, and human rights. By examining both opportunities and challenges, it emphasizes the need for responsible and well-regulated implementation of genetic technologies.Bringing together current research and applied insights, this volume offers a clear and balanced perspective on the evolving role of genome editing in advancing healthcare worldwide.

Produktinformation

Utgivningsdatum: 2026-08-17
Mått: 152 x 229 x 19 mm
Vikt: 660 g
Format: Inbunden
Språk: Engelska
Antal sidor: 250
Förlag: Apple Academic Press Inc.
ISBN: 9781779643810

Utforska kategorier

Mer om författaren

Bhupinder Singh, PhD, is Professor at Sharda University, India, and Honorary Professor at the University of South Wales, UK. He has over 16 years of experience and has authored numerous publications and conference presentations across law and emerging technologies.Rishabha Malviya, PhD, is Associate Professor at Galgotias University, India, with expertise in pharmaceutics and drug delivery. He has published over 200 papers, holds multiple patents, and is listed among the world’s Top 2% Scientists per Stanford University.Sahil Lal, PhD, is Assistant Professor of Law at Galgotias University, India. His work focuses on intellectual property and emerging technologies, particularly artificial intelligence and innovation policy.Sathvik Belagodu Sridhar, PhD, is Associate Dean and Professor at RAK Medical and Health Sciences University, UAE, with over 25 years of experience in clinical pharmacy and pharmacovigilance research.

Recensioner i media

“A thorough, multidisciplinary examination of how genetic editing is revolutionizing medicine and providing fresh hope in the battle against complicated illnesses. . . . An extensive range of chapters on the ethical, legal, and societal consequences of gene editing, with a focus on human rights concerns and the legal frameworks that must adapt to incorporate the impact of gene editing. . . . An essential resource for healthcare experts, researchers, clinicians, and biomedical scientists in the future of healthcare and genetic technology.”—From the Foreword by Dr. Dhruv Galgotia, CEO, Galgotias University, Greater Noida, India

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.